Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470606) titled 'Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain' on March 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: The University of Texas Health Science Center at San Antonio
Condition:
Brain Tumor
Intervention:
Drug: Memantine
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: March 2026
Target Sample Size: 108
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07470...